Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05049967 · ClinicalTrials.gov registry record
iKnow: A Prospective Study to Evaluate the Use of Multi-omics in Multi-System, Early Onset Disorders
A clinical trial of Genetic Disease, sponsored by Illumina.
- Active
- Registry status
- 150
- Enrollment target
- 1
- Study location
NCT05049967 is a study of Genetic Disease that is active but no longer recruiting, run by Illumina. The registered enrollment target is 150 participants, below the 2,556-participant average among 30 other Genetic Disease trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05049967, a study of Genetic Disease, is active but no longer recruiting, sponsored by Illumina.
- ACTIVE NOT RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
Prospective observational study to further understand the value that a multi-omic approach has in individuals with a multi system, early onset disorder that does not have a molecular diagnosis by whole genome sequencing.
Conditions Studied
Study Locations (1)
Pennsylvania
- Clinic for Special Children - Strasburg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2021-11-09 |
| Est. Completion | 2024-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05049967
The ClinicalTrials.gov registry entry for NCT05049967 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,556-participant average among 30 other Genetic Disease trials with a reported enrollment target (94% lower). The listed sponsor is Illumina, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Genetic Disease appearing as the primary indexed condition, and to 0 interventions.
NCT05049967 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05049967 about?
NCT05049967 is a clinical study titled "iKnow: A Prospective Study to Evaluate the Use of Multi-omics in Multi-System, Early Onset Disorders". Prospective observational study to further understand the value that a multi-omic approach has in individuals with a multi system, early onset disorder that does not have a molecular diagnosis by whole genome sequencing.
What is the current status of trial NCT05049967?
This trial is currently active not recruiting. The enrollment target is 150 participants. The study started on 2021-11-09. Estimated completion is 2024-12-31.
What conditions does trial NCT05049967 study?
This clinical trial studies the following conditions: Genetic Disease.
Who is sponsoring clinical trial NCT05049967?
This trial is sponsored by Illumina, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05049967 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Genetic Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
An Adaptive Clinical Trial of BeginNGS Newborn Screening for Hundreds of Genetic Diseases by Genome Sequencing
RECRUITING · NA
-
Delineating the Molecular Spectrum and the Clinical, Imaging and Neuronal Phenotype of Chopra-Amiel-Gordon Syndrome
RECRUITING
-
Rett Syndrome Registry
RECRUITING
-
Natural History Study of Patients with HPDL Mutations
RECRUITING
-
Diagnostic Odyssey: Whole Genome Sequencing (WGS)
RECRUITING
-
Clinical and Genetic Evaluation of Individuals With Undiagnosed Disorders Through the Undiagnosed Diseases Network
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.